HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy.

AbstractPURPOSE:
To compare the relative expression of peroxiredoxin (Prx) proteins in normal human corneal endothelium with endothelium in corneas affected by Fuchs' endothelial dystrophy (FED) and between normal human endothelium and epithelial/stromal tissue.
METHODS:
Human corneal endothelial cell-Descemet's membrane (HCEC-DM) complexes from normal and FED corneal buttons were dissected from the epithelium/stroma. For proteomic analysis, HCEC-DM protein extracts were separated by using two-dimensional gel electrophoresis. Relative differences in protein spot density was analyzed. Proteins of interest, including Prx isoforms, were identified by MALDI-TOF (matrix-assisted desorption ionization-time of flight) mass spectrometry. Western blot analysis compared the relative expression of Prx isoforms in normal and FED endothelium and between normal endothelium and normal epithelium/stroma. Expression of Prx-2 mRNA was compared by using real-time PCR.
RESULTS:
Proteomic analysis identified differences in the relative expression of Prx isoforms between normal and FED endothelium. Western blot analysis confirmed that expression of Prx-2, -3, and -5 was significantly decreased (P < 0.05) in FED cells. Normal HCECs expressed significantly (P < 0.05) higher levels of Prx-2 and -3 than did the epithelium/stroma. Expression of Prx-5 was not significantly different (P > 0.05) in the endothelium versus the epithelium/stroma. Real-time PCR analysis revealed that Prx-2 mRNA was significantly decreased (P = 0.027) in FED samples.
CONCLUSIONS:
Prx proteins were identified in human corneal endothelium. The fact that Prx-2 and -3 were expressed at significantly higher levels in HCEC-DM compared with the epithelium/stroma reflects the different physiologic activities of individual corneal cell types. Significantly decreased expression of Prx-2, -3, and -5 in FED may suggest an alteration in the ability of endothelial cells to withstand oxidant-induced damage and may be closely related to the pathogenesis of this disease.
AuthorsUla V Jurkunas, Ian Rawe, Maya S Bitar, Cheng Zhu, Deshea L Harris, Kathryn Colby, Nancy C Joyce
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 49 Issue 7 Pg. 2956-63 (Jul 2008) ISSN: 1552-5783 [Electronic] United States
PMID18378575 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Protein Isoforms
  • PRDX2 protein, human
  • PRDX3 protein, human
  • PRDX5 protein, human
  • Peroxiredoxin III
  • Peroxiredoxins
Topics
  • Aged
  • Aged, 80 and over
  • Blotting, Western
  • Corneal Stroma (metabolism)
  • Down-Regulation
  • Endothelium, Corneal (metabolism)
  • Epithelium, Corneal (metabolism)
  • Female
  • Fuchs' Endothelial Dystrophy (metabolism)
  • Humans
  • Male
  • Middle Aged
  • Peroxiredoxin III
  • Peroxiredoxins (metabolism)
  • Protein Isoforms (metabolism)
  • Proteomics
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: